Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inflammation and cancer: back to Virchow?
Balkwill F, Mantovani A. Balkwill F, et al. Lancet. 2001 Feb 17;357(9255):539-45. doi: 10.1016/S0140-6736(00)04046-0. Lancet. 2001. PMID: 11229684 Review.
Primary hypothyroidism associated with interferon therapy of breast cancer.
Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Fentiman IS, et al. Among authors: balkwill fr. Lancet. 1985 May 18;1(8438):1166. doi: 10.1016/s0140-6736(85)92475-4. Lancet. 1985. PMID: 2860373 Clinical Trial. No abstract available.
Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model.
Dias S, Thomas H, Balkwill F. Dias S, et al. Among authors: balkwill f. Int J Cancer. 1998 Jan 5;75(1):151-7. doi: 10.1002/(sici)1097-0215(19980105)75:1<151::aid-ijc23>;2-i. Int J Cancer. 1998. PMID: 9426704
The anti-proliferative activity of interferon-gamma on ovarian cancer: in vitro and in vivo.
Wall L, Burke F, Smyth JF, Balkwill F. Wall L, et al. Among authors: balkwill f. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S149-51. doi: 10.1006/gyno.2002.6707. Gynecol Oncol. 2003. PMID: 12586108 Review. No abstract available.
Barrett's metaplasia.
Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Jankowski JA, et al. Among authors: balkwill f. Lancet. 2000 Dec 16;356(9247):2079-85. doi: 10.1016/S0140-6736(00)03411-5. Lancet. 2000. PMID: 11145505
Cancer and inflammation: implications for pharmacology and therapeutics.
Balkwill F, Mantovani A. Balkwill F, et al. Clin Pharmacol Ther. 2010 Apr;87(4):401-6. doi: 10.1038/clpt.2009.312. Epub 2010 Mar 3. Clin Pharmacol Ther. 2010. PMID: 20200512 Review.
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.
Balkwill F, Bast RC, Berek J, Chenevix-Trench G, Gore M, Hamilton T, Jacobs I, Mills G, Souhami R, Urban N, Orsulic S, Smyth J. Balkwill F, et al. Eur J Cancer. 2003 Sep;39(13):1818-27. doi: 10.1016/s0959-8049(03)00511-2. Eur J Cancer. 2003. PMID: 12932658
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours.
Scotton C, Milliken D, Wilson J, Raju S, Balkwill F. Scotton C, et al. Among authors: balkwill f. Br J Cancer. 2001 Sep 14;85(6):891-7. doi: 10.1054/bjoc.2001.2020. Br J Cancer. 2001. PMID: 11556842 Free PMC article.
Cytokine amplification and inhibition of immune and inflammatory responses.
Balkwill F. Balkwill F. J Viral Hepat. 1997;4 Suppl 2:6-15. doi: 10.1111/j.1365-2893.1997.tb00175.x. J Viral Hepat. 1997. PMID: 9429205 Review.
The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients.
Thavasu P, Propper D, McDonald A, Dobbs N, Ganesan T, Talbot D, Braybrook J, Caponigro F, Hutchison C, Twelves C, Man A, Fabbro D, Harris A, Balkwill F. Thavasu P, et al. Among authors: balkwill f. Cancer Res. 1999 Aug 15;59(16):3980-4. Cancer Res. 1999. PMID: 10463595 Clinical Trial.
269 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page